Invesco Biotechnology & Genome ETF
PBE
#1996
ETF rank
$0.42 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
$97.64
Share price
-1.10%
Change (1 day)
38.41%
Change (1 year)

Invesco Biotechnology & Genome ETF - Holdings

Etf holdings as of September 5, 2026Number of holdings: 33

Full holdings list

Weight %NameTickerShares Held
5.22%
Royalty Pharma PLCRPRX345058
5.13%
Gilead Sciences IncGILD143969
5.05%
Biogen IncBIIB97015
5.02%
Amgen IncAMGN48427
5.02%
Regeneron Pharmaceuticals IncREGN25700
4.99%
Vertex Pharmaceuticals IncVRTX38743
4.92%
Natera IncNTRA63603
4.90%
Illumina IncILMN95198
3.28%
Sarepta Therapeutics IncSRPT617457
2.98%
Novavax IncNVAX1237529
2.87%
Exelixis IncEXEL205960
2.80%
Neurocrine Biosciences IncNBIX76177
2.79%
BioCryst Pharmaceuticals IncBCRX1188428
2.78%
Legend Biotech CorpLEGN548463
2.78%
TG Therapeutics IncTGTX210789
2.78%
Halozyme Therapeutics IncHALO106868
2.77%
BioMarin Pharmaceutical IncBMRN176677
2.75%
Ardelyx IncARDX3090544
2.74%
QIAGEN NVQGEN267632.3786
2.69%
Incyte CorpINCY90061
2.68%
AnaptysBio IncANAB200144
2.67%
Protagonist Therapeutics IncPTGX77579
2.66%
Veracyte IncVCYT265268
2.60%
PTC Therapeutics IncPTCT159001
2.59%
United Therapeutics CorpUTHR22527
2.56%
Vericel CorpVCEL270293
2.54%
Repligen CorpRGEN64298
2.52%
ACADIA Pharmaceuticals IncACAD382153
2.52%
Moderna IncMRNA73546
2.36%
Collegium Pharmaceutical IncCOLL425279
0.04%
Invesco Government & Agency PortfolioAGPXX190826.33
0.00%
CASH & EQUIVALENTSUSD5728
0.00%
USD Pending DividendsUSDPDV0